This application claims priority to and the benefit of Korean Patent Application No. 2023-0081703, filed on Jun. 26, 2023, the disclosure of which is incorporated herein by reference in its entirety.
The present invention relates to a nanoscale molecularly imprinted polymer thin film for small molecule detection, a method of manufacturing the same, and an electrochemical sensor using the same.
Detection of small molecules such as metabolites, neurotransmitters, and hormones can provide useful biological information for the diagnosis of specific diseases, the prediction of treatment responses, and health condition monitoring. Among various sensing techniques, electrochemical detection has great advantaged for point-of-care (PoC) applications due to its merits, such as easy miniaturization, low cost, and fast responses.
While electroactive small target molecules may be easily detected by direct charge transfer from their own redox reactions on electrode surfaces, electrochemically inactive small molecules can be detected by monitoring the electroactive products released in highly selective enzymatic reactions with target molecules.
However, electrically inactive small molecules, not involving proper enzymatic reactions generating electroactive products, can be detected with affinity-based (bio) sensors, in which small target molecules selectively bind to bioreceptors (e.g., antibodies and aptamers) or biomimetic receptors (e.g., molecularly imprinted polymers).
In general, affinity-based (bio) sensors exhibit extremely high binding affinity, which enables highly selective detection of target molecules but there is difficulty in regenerating receptors, making repetitive and continuous measurements difficult. Moreover, existing affinity-based electrochemical (bio) sensors require either electroactive labels such as labeled secondary antibodies for electrical signal detection or external solutions containing redox probes for electrochemical impedance spectroscopic detection, which are not suitable for PoC application.
Therefore, a great deal of effort has been put into developing “label-free” and “bind-and-read” electrochemical sensing techniques by co-immobilizing (bio) receptors and redox probes on electrode surfaces for decentralized on-site monitoring of clinically important molecules.
In the development of affinity-based (bio) sensors for small molecules, ultrasensitive detection methods are highly desired because of the small molecules' low physiological concentrations (10-12 to 10−9 M level). However, ultrasensitive detection of small molecules faces major challenges because of their inherent imbalance in target-to-receptor size ratio.
Conventional bioreceptors, such as antibodies and aptamers (6 kDa to 180 kDa), are much larger than target small molecules (≤1 kDa), so there is little apparent change in their physicochemical properties upon their binding events. In order to achieve highly sensitive and reliable detection, the target-to-receptor size ratio should be higher than 0.3.
Thus, some efforts have been made to reduce the size of biological receptors by utilizing nanobodies and truncated aptamers. However, the above problem has not been completely resolved because the resulting target-to-receptor size ratio is still smaller than 0.3 [Non-patent Documents 1 and 2].
Reducing the molecularly imprinted polymer (MIP) thickness could increase the target-to-receptor size ratio, which results in pronounced changes in their physicochemical properties upon their binding events, thus leading to the highly sensitive detection of small target t molecules. Conventionally, electrochemical detections in MIPs are mostly based on the measurement of charge transfer resistance (Rct) at the MIP interface (interface with solution of entire MIP including cavity) upon the binding of target molecules using an external redox probe in the measurement solution via the electrochemical impedance spectroscopy (EIS) technique (referred to as Rct EIS) [Non-patent Document 3]. However, because the Rct of the thin film itself is very low, the binding of small target molecules may not induce noticeable changes in Rct, so Rct EIS may not be suitable for the detection of small molecules in nanometer-sized thin MIP films.
Therefore, an alternative that enables highly sensitive signaling while resolving the imbalance in the target-to-receptor size ratio is needed
Therefore, the present inventors have made research efforts to solve the above problems, and as a result, they manufactured a nano-sized molecularly imprinted polymer (MIP) that does not require the cumbersome process of replacing the solution from a target binding solution (biological sample) to a redox measurement solution and an electrode cleaning step and that allows on-site electrochemical regeneration, overcoming the limitations of existing affinity-based (bio) sensors, such as single measurement or the need for cumbersome and complicated regeneration processes, and enabling repeated/continuous measurement. Consequently, the present inventors completed the present invention by developing a novel electrochemical sensing technique for ultrasensitive detection of small molecules.
Therefore, one object of the present invention is to provide a small molecule-selective MIP thin film manufactured by electrochemically copolymerizing β-cyclodextrin (β-CD) as receptor and methylene blue (MB) as a redox probe, and a method of manufacturing the same.
In addition, another object of the present invention is to provide an electrochemical biosensor based on the MIP and an electrochemical sensor for detecting small molecules using the same.
Hereinafter, the present invention will be described in more detail.
The present invention relates to a nanoscale MIP thin film for small molecule detection, a method of manufacturing the same, and an electrochemical sensor using the same.
As one embodiment, the present invention includes a nanoscale MIP thin film for small molecules, in which a plurality of specific recognition spaces for small molecules of 1000 Da or less are formed, wherein a receptor (e.g., β-cyclodextrin) polymer is present at one end of the specific recognition spaces, a redox probe is present in a wire form, and the small molecules are a steroid hormone or a protein.
In the present invention, the term “small molecule” refers to a steroid hormone with a molecular weight of 1000 Da or less (1 to 1000 Da), and the steroid hormones include cortisol (362.46 g/mol), melatonin (232.278 g/mol), and the like. In the present invention, a small molecule is used as a target analyte (detection).
Cortisol is a representative non-electroactive small molecule (molecular weight: 362.46 Da), and it was selected as a target analyte of the present invention because it is present at a low physiological concentration (serum 83 to 690×10−9 M, sweat 0.66 to 397.3×10−9 M, saliva 2.2 to 27.3×10−9 M) along with steroids having a similar chemical structure.
The term “molecularly imprinted polymer (MIP)” used in the present specification refers to a polymer that is formed by synthesizing a polymer using a suitable template (a small molecule such as cortisol in the present invention) and removing the template so that the polymer may memorize the shape of the template and include the same space as the template. MIPs have been applied in various fields such as detection, recognition, removal, extraction, delivery, and analysis of specific substances due to their high selectivity and stability.
The technique for obtaining the MIPs, that is, the molecular imprinting technique, is capable of forming a three-dimensional polymer structure by adding any template material to a solution in which monomers are dissolved, and after removing the template material therefrom, cavities that may selectively bind to the template material are formed.
The MIP of the present invention is prepared by electrochemically copolymerizing small molecules, a receptor, and a redox probe, and then removing the small molecules. Preferably, electrochemical polymerization may be performed with the small molecules, the receptor, and the redox probe at a molarity (M) ratio of 1:0.5 to 1.5:5 to 15. The above ratio is a ratio for optimizing the performance of a sensor, and when the ratio is changed, a change in detection performance through the synthesized polymer thin film occurs.
The electrochemical copolymerization may be performed by 7 to 12 cycles of cyclic voltammetry (CV) scans between-2.0 and 2.2 V at a scan rate of 50 to 200 mV/s.
In the present invention, the term “cavity” refers to a space that may selectively bind to a template material within an MIP and means “specific molecular recognition space.” To create a specific molecular recognition space, extraction of a target molecule (small molecule) from an MIP thin film may be achieved by a number of methods, including washing, sonication, and electrochemical peroxidation. Preferably, extraction of the small molecules from the polymer film includes applying electrochemical peroxidation to the MIP thin film.
“Electrochemical peroxidation” oxidizes functional groups of a receptor through CV to weaken the hydrogen bond between these functional groups and the small molecules, allowing the small molecules to be separated from the MIP.
In the present invention, the term “receptor” refers to a substance or polymer itself that is fixed to a surface of an electrode and selectively binds to a target. Monomers for forming the polymer may include β-cyclodextrin, pyrrole, ortho-phenylenediamine. The selective binding means that the (hydrogen) bond between the receptor and the small molecules in the MIP becomes weaker under oxidizing conditions.
In the present invention, the term “redox probe” may be a molecule or a component part of the MIP, which may undergo an oxidation or reduction reaction. In addition, it is preferable in the present invention to use Prussian Blue, Ferrocene, or methylene blue as a redox probe that may generate constant signals for repetitive electrochemical oxidation/reduction reactions.
In one embodiment of the present invention, “β-cyclodextrin polymer” in an MIP serves as a recognition element for a target analyte, and a co-bound polymethylene blue (PMB) serves as a “wire” in which a polymer chain connects a redox site with a resonance charge to an electrode, and when a target molecule (small molecule) binds to the cavity within the MIP, electron transfer through the adjacent PMB is disrupted, lowering the conductance of the PMB wire and reducing resonant quantum conductance.
In the present invention, the term “nanoscale MIP thin film” refers to a thin film having a thickness of 5 nm or less, preferably 0.1 to 5 nm. The thickness of an MIP film is an important factor that affects not only the reproducibility of the sensor but also the recognition ability of the film. The film thickness may be controlled by adjusting the concentration of monomers and the number of polymerization cycles.
In addition, the present invention includes method of manufacturing a nanoscale MIP thin film for small molecules, including:
All of the above-described content in relation to the MIP thin film may be directly applied or adapted to the method of manufacturing the MIP thin film.
The “quantum electrochemical detection device” used in the present specification may be a device measuring resonant quantum conductance using quantum electrochemical impedance spectroscopy (EIS).
The term “quantum electrochemical impedance spectroscopy (EIS)” used in the present specification refers to a method of measuring the interference with electron transfer through the oxidation/reduction material contained in an MIP thin film when a target material is bound to the thin film as conductance. While conventional EIS reads the charge transfer resistance of a thin film shown in the Nyquist plot, quantum EIS reads the resonant quantum conductance, which is a quantum characteristic of nanoscale thin films.
The electrode may be pretreated by ultrasonic treatment in ethanol and deionized water and then performing an electrochemical potential sweep.
The small molecules may be removed from an MIP through electrochemical peroxidation in which functional groups of a receptor are oxidized through CV to weaken the hydrogen bond between the functional groups and the small molecules. Specifically, small molecules may be removed by performing 7 to 12 cycles of CV scans between 0 and 0.9 V at a scan rate of 50 to 150 mV/s.
In addition, the present invention includes a method of detecting small molecules, including:
Step 1 is a step of bringing a biological sample into contact with a manufactured quantum electrochemical detection device, and it includes noncovalently bonding a targeted small molecule present in the biological sample to a cavity generated in the MIP thin film through hydrogen bonding and a size effect.
The biological sample is selected from the group consisting of plasma, serum, saliva, urine, mucus, and tears of a human or animal.
The contact means bringing a biological sample into contact with a surface of the manufactured quantum electrochemical detection device for 2 to 20 minutes.
Step 2 is a step of reading the electrical characteristics that change when a small molecule binds to the MIP thin film using a quantum electrochemical detection device, and it includes applying a direct current (DC) voltage (−0.1 V to −0.3 V), which is an intermediate redox voltage of a redox probe immobilized in the MIP thin film, to the detection device as and simultaneously applying an alternating current (AC) voltage of 5 to 20 mV while changing the frequency (0.01 Hz to 10 kHz).
Step 3 is a step of converting the data obtained when the voltage is applied to resonant quantum conductance, wherein the data may be converted into data on capacitance using Mathematical Formulas 6 and 7 described in the Examples, and the resonant quantum conductance may be calculated through the data on capacitance (see Mathematical Formula 21).
It is possible to calculate the concentration of cortisol from the resonant quantum conductance through quantum electrochemical impedance measurement.
In one embodiment, the present invention may further include a step of calculating the concentration of small molecules in a biomaterial using the measured resonant quantum conductance and a previously prepared calibration curve for each concentration of the small molecules.
Specifically, to detect cortisol as a small molecule, calculation was performed using the calibration curve in the attached drawing
The term “resonant quantum conductance” used in the present specification refers to the conductance when current charging/discharging occurs at the same rate in the oxidized/reduced portions of the nano-sized thin film (when density of state (DOS) reaches a maximum value).
The present invention also includes an electrochemical biosensor for small molecule detection, including the MIP thin film for small molecules.
In the present invention, the term “electrochemical sensor” may be understood as a device configured to detect the presence and/or measure the concentration of an analyte through an electrochemical oxidation and/or reduction reaction.
In one embodiment, an electrochemical biosensor for small molecule detection including the MIP thin film for small molecules utilizes changes in the quantum properties of the thin film. The changes in the quantum properties of the thin film are caused by a local change that occurs when a small molecule binds to the nanoscale thin film. As one embodiment, in an Example of the present invention,
In addition, in one embodiment where the small molecule is cortisol, the MIP thin film of the biosensor may be formed by copolymerization of a receptor polymer (e.g., β-cyclodextrin polymer) and a redox probe (e.g., polymethylene blue), and it may preferably be a single layer. In addition, the MIP thin film is preferably formed by electrochemical polymerization of cortisol, β-cyclodextrin, and methylene blue at a molarity (M) ratio of 1:0.5 to 1.5:5 to 15. When the molar concentration of each material is outside the above range or the thickness becomes thicker, changes in electrochemical properties depending on the presence or absence of a bond between the MIP thin film and a target molecule may be detected, but there is a disadvantage in that accuracy is significantly reduced. All of the above-described content regarding the MIP thin film may be directly applied or adapted to the biosensor.
Three electrodes (three terminal electrodes) may be used in the biosensor. In addition, the biosensor may have a structure in which a working electrode, a reference electrode, and a counter electrode are formed in the same solution. In the biosensor, a change in resonant quantum conductance occurs depending on the presence or absence of a bond between an MIP thin film and a small molecule. In other words, the biosensor does not simply sense differences in electrical conductance or resistance, but it detects a small molecule using the changes in resonant quantum conductance due to the changes in the current flowing through a redox material in the MIP thin film when the frequency of the AC voltage is changed while both DC and AC voltages are applied at the same time for resonant quantum conductance.
Since the sensor according to the present invention exhibits a detection limit of 1.0×10−13 to 1.0×10−6, which is much lower than that of the existing electrochemical sensors, ultrasensitive on-site detection is possible.
The sensor according to the present invention may be commercialized so that the small molecule concentration may be displayed on the display when the sensor is immersed in a sample (in the same manner as a blood sugar sensing device).
While measurements based on EIS and differential pulse voltammetry (DPV) are not sensitive enough to generate a distinct signal change induced by a local change upon a target analyte binding event because they basically rely on the measurement of the redox reaction governed by electron transfer throughout the entire film, the measurement of resonant quantum conductance reflects a local change in the charge density of the redox probe wire in the nanoscale MIP thin films and thus offers superior sensing performance in terms of sensitivity, detection limit, and dynamic range compared to other conventional methods.
In addition, the present invention provides a method of manufacturing a biosensor for small molecule detection using changes in resonant quantum conductance, including: forming an MIP thin film on a working electrode (Step A); forming a nanoscale thin film of 5 nm or less by performing electrochemical polymerization of small molecules, β-cyclodextrin, and a redox probe at a molarity (M) ratio of 1:0.5 to 1.5:5 to 15 on the working electrode and then electrochemically separating the small molecules from the electropolymerized thin film (Step B).
In Step A, electrochemical copolymerization is possible by reducing the functional groups of the receptor through CV and forming hydrogen bonds between the small molecules and the functional groups of the receptor. Specifically, electrochemical copolymerization is performed by 7 to 12 cycles of CV scans between-2.0 and 2.2 V at a scan rate of 50 to 200 mV/s.
Step B is carried out through an electrochemical change in the structure of the MIP thin film. In other words, the functional groups of the receptor are oxidized through CV to weaken the hydrogen bond between the small molecules and the functional groups of the receptor, allowing the small molecules to be extracted. The electrochemical MIP thin film structural change in Step B is performed by 7 to 12 cycles of CV scans between 0.0 and 0.9 V at a scan rate of 50 to 200 mV/s.
In addition, the present invention provides a method of sensing a small molecule using a biosensor for small molecule detection including a working electrode, a reference electrode, and a counter electrode provided in one cell and spaced apart from each other; an electrolyte solution in which the three electrodes are immersed; an MIP thin film electrochemically copolymerized with the working electrode and binding to a small molecule, the MIP film having a thickness of 5 nm or less and including a redox probe, and formed of the MIP thin film for small molecule detection, the method including: bringing a biological sample into contact with the MIP thin film; and measuring the quantum properties of the thin film before and after contact between the quantum electrochemical detection device and the sample and confirming changes in resonant quantum conductance.
In one embodiment, the sensing method is performed by detecting a change in resonant quantum conductance depending on the presence or absence of a bond between an MIP thin film and a small molecule.
In other words, the biosensor does not simply sense differences in electrical conductance or resistance, but it detects a small molecule using the changes in resonant quantum conductance due to the changes in the current flowing through a redox material in the MIP thin film when the frequency of the AC voltage is changed while both DC and AC voltages are applied at the same time for resonant quantum conductance.
The above and other objects, features and advantages of the present invention will become more apparent to those of ordinary skill in the art by describing exemplary embodiments thereof in detail with reference to the accompanying drawings, in which:
Hereinafter, the present invention will be described in more detail through examples according to the present invention, but the scope of the present invention is not limited to the examples presented below.
The following chemicals were used without separate purification steps: 1.00 μm alumina powder (40-10079, Buehler), 0.05 μm gamma alumina powder (90-187050, ALLIED), ethanol (94.5%, DAEJUNG), β-cyclodextrin hydrate (99%, Sigma Aldrich), methylene blue hydrate (≥97%, Sigma Aldrich), hydrocortisone (≥98%, Sigma Aldrich), phosphate buffered saline (10×, Sigma Aldrich), sulfuric acid (95.0-98.0%, Sigma Aldrich), prednisolone (≥99%, Sigma Aldrich), progesterone (≥99%, Sigma Aldrich), calcium chloride (anhydrous, ≥97%, Sigma Aldrich), potassium hexacyanoferrate (II) trihydrate (≥99.95%, Sigma Aldrich), potassium hexacyanoferrate (III) (≥99.0%, Sigma Aldrich), sodium bicarbonate (≥99.7%, Sigma Aldrich), sodium phosphate dibasic (>99%, Sigma Aldrich), potassium chloride (≥99%, Sigma Aldrich), urea (≥99%, Sigma Aldrich), sodium hydroxide (≥98%, Sigma Aldrich), a cortisol solution (1 mg/mL in methanol, Sigma Aldrich), sodium chloride (>99%, Sigma Aldrich), a cortisol-D4 (9, 11, 12, 12-D4) solution (100 μg/ml in methanol, Sigma Aldrich), pure ethyl alcohol (200 proof, Sigma Aldrich), and methanol (≥99%, Sigma Aldrich); Deionized (DI) water for all solutions was purified using a Milli-Q water purification system (Millipore, Bedford, MA, USA).
Unless otherwise stated, all solutions were dissolved in a 1× PBS (pH 7.4) solution.
All electrochemical experiments were performed using a CS350 potentiostat (Corrtest Instruments Co., Ltd.). A three-electrode electrochemical cell was composed of a GCE (MF-2012, BAS, Inc., 3 mm in diameter) as a working electrode, a platinum counter electrode (002222, ALS Co., Ltd), and an Ag/AgCl (3 M NaCl) reference electrode (MF-2052, BAS, Inc.). The FE-SEM images were obtained using JEOL-7800F (JEOL, Ltd.). The AFM images were obtained in a tapping mode using NX-10 (Park Systems). UV-vis spectra were acquired using V770 (JASCO, Ltd.). Liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) analysis of cortisol in human saliva samples was performed using Ultimate 3000 RS-Q-Exactive Orbitrap Plus (ThermoFisher Scientific).
Hereinafter, the MIP film for cortisol is referred to as “MICP.”
In order to charge/discharge electrochemical redox states of “PMB wire” spanning the space between the electrode and redox site, the conduction of a specific potential gradient (dV) induces a resonant exchange of electrons, where V is potential. The chemical potential (u) of this wire is expressed as Mathematical Formula 1:
Finally, current (i) is related to resonant quantum conductance (G) through Mathematical Formula 5:
Capacitance data was obtained from quantum EIS experiments using Mathematical Formulas 6 and 7 below [Garrote, B. L.; Santos, A.; Bueno, P. R. Label-free capacitive assaying of biomarkers for molecular diagnostics. Nature Protocols 2020, 15 (12), 3879-3893.].
Using Mathematical Formulas 6 and 7 below, C′ and C″ can be calculated using Zim, Zre, |Z|2, and ω which are data values obtained after measuring EIS, respectively.
The thickness of each polymer film (PMB and CDP) on the GCE can be estimated from the corresponding CV peaks generated during the electrochemical copolymerization process. The surface coverage (I′) of PMB and CDP can be expressed respectively as Mathematical Formula 8 [Marinho, M. I. C.; Cabral, M. F.; Mazo, L. H. Is the poly (methylene blue)-modified glassy carbon electrode an adequate electrode for the simple detection of thiols and amino acid-based molecules? Journal of Electroanalytical Chemistry 2012, 685, 8-14.].
where v is the molecular volume, 400 cm3/mol for PMB and 317 cm3/mol for CDP. [Tan, L.; Xie, Q.; Yao, S. Electrochemical and spectroelectrochemical studies on pyridoxine hydrochloride using a poly (methylene blue) modified electrode. Electroanalysis: An International Journal Devoted to Fundamental and Practical Aspects of Electroanalysis 2004, 16 (19), 1592-1597.; Sandilya, A. A.; Natarajan, U.; Priya, M. H. Molecular view into the cyclodextrin cavity: structure and hydration. ACS Omega 2020, 5 (40), 25655-25667]. The film thickness (d) of the PMB and CDP was determined to be 1.97 and 3.11 nm, respectively.
The plots of relative G response versus binding time at various cortisol concentrations were fitted by using “binding kinetics (one ligand concentration)” to estimate koff and kon using Mathematical Formula 10 below [Zeilinger, M.; Pichler, F.; Nics, L.; Wadsak, W.; Spreitzer, H.; Hacker, M.; Mitterhauser, M. New approaches for the reliable in vitro assessment of binding affinity based on high-resolution real-time data acquisition of radioligand-receptor binding kinetics. EJNMMI Research 2017, 7 (1), 1-13.; Jarmoskaite, I.; AlSadhan, I.; Vaidyanathan, P. P.; Herschlag, D. How to measure and evaluate binding affinities. Elife 2020, 9, e57264.].
From the G measurement, the association constant (ka) for the binding events between the MICP and target cortisol was determined using three different adsorption models, namely Langmuir (Mathematical Formula 13), Freundlich (Mathematical Formula 14), and Langmuir-Freundlich models (Mathematical Formula 15). These three models are mainly used to determine the association constant of MIPs because they can more accurately calculate the affinity distribution of the cavities of MIPs, which can have both homogeneous and heterogeneous characteristics [Umpleby, R. J.; Baxter, S. C.; Chen, Y.; Shah, R. N.; Shimizu, K. D. Characterization of molecularly imprinted polymers with the Langmuir Freundlich isotherm. Analytical Chemistry 2001, 73 (19), 4584-4591.].
The resulting parameter K (KLF for Langmuir-Freundlich model, KL for Langmuir model) is related to the mean association constant Ka.
The bare GCE was polished with 1.0 μm and 0.05 μm alumina powder on a polishing cloth. Then, it was ultrasonically treated at 40 Hz and 70 W in a solution in which ethanol and deionized (DI) water were mixed at a volume ratio of 1:1 for 10 min and an electrochemical potential sweep was carried out in the potential range of −0.2 V to 1.6 V at 100 mV/s (20 scans) in a 0.5 M H2SO4 solution. Subsequently, the MICP was electrochemically copolymerized in a solution containing 1 mM MB, 100 μM β-CD, and 100 μM cortisol by 10 CV cycles between −2.0 and 2.2 V at a scan rate of 100 mV/s. The extraction of the cortisol template molecule was carried out electrochemically in 1× PBS by CV scanning between 0 and 0.9 V for 10 cycles at a scan rate of 100 mV/s until all cortisol molecules were removed from the imprinted film.
As a control experiment, the CDP only, PMB only, and NICP were synthesized using the same procedure without MB, β-CD, and the cortisol template, respectively.
The CDP, PMB, and MICP were synthesized on indium tin oxide (ITO) glass (Omniscience, Korea) (for UV-vis) and on the glassy carbon plate (Dasom RMS, Korea) (for SEM and AFM) using the same procedure.
Unless otherwise stated, all electrochemical characterizations were carried out in 1× PBS. CV was performed in the −0.5 V to 0.5 V potential range with a scan rate of 100 mV/s to characterize the properties of the polymer films and the signal stability of PMB in MICPs. After 10 min incubation in cortisol solutions, various cortisol concentrations were measured to obtain a linear regression equation for each electrochemical reaction. All calibration curves were plotted by using the relative response of each electrochemical signal that was obtained by the following Mathematical Formula 16.
where R[target] is the signal transduced for a certain target concentration, and Rblank is the signal of the blank. The limit of detection (LOD) of the assay was defined by Mathematical Formula 17.
Artificial saliva (AS) was prepared in DI water by adding the major saliva constituents: NaCl (0.4 mg/ml), CaCl2) (0.6 mg/ml), NaHCO3 (0.3 mg/ml), Na2HPO4 (0.6 mg/ml), KCl (0.4 mg/ml), and urea (4 mg/ml). Afterward, NaOH was added to the solution to obtain a pH of 7.4. The prepared AS was stored at 4° C. until further use. Various cortisol concentrations, within saliva, were measured using in AS for a calibration curve, using the same procedure with the buffer solution. For salivary cortisol monitoring, saliva samples were collected every six hours of the day (8 a.m., 2 p.m., 8 p.m., and 2 a.m.) with commercially available Salivette® (Sarstedt, Nümbrecht, Germany). The Salivette® tubes were centrifuged for 2 min at 1,000×g at 4° C. to remove debris and the supernatant was frozen at −20° C. The MICP-based cortisol sensor was repetitively used four times to verify its accuracy and reusability by measuring saliva samples collected at 8 a.m. and 2 a.m., respectively, involving regeneration between each measurement. The circadian rhythms were tracked throughout the day, and the results were validated by LC-MS/MS analysis using Ultimate 3000 RS-Q-Exactive Orbitrap Plus (Thermo Fisher Scientific). Solvent composition and tracking rate parameters for LC were detailed in Table 1 and MS/MS parameters for gas, temperature, and voltage settings were summarized in Table 2.
The cortisol-selective MICP was prepared by electrochemically copolymerizing β-CD and MB, which resulted in a copolymer film of CDP and PMB. The CDP immobilized within the MICP serves as a recognition element for cortisol and the co-immobilized PMB serves as a redox probe, as shown in
Such phenomenon can also be explained using the equivalent circuit of the MICP (
Consequently, the binding of cortisol to the MICP induces a decrease in N which in turn leads to a decrease in the conductance of the MICP as explained above. As shown in
The experimental details are described in the Examples.
The first anodic peak at −0.1 V indicates the oxidation of the MB monomer involving the formation of cations on one of the two tertiary amine groups, which further reacts with another tertiary amine group and results in polymerized MB (
Simultaneously, β-CD also underwent the polymerization process and showed a well-defined cathodic peak at −0.6 V. From the 2nd CV cycle, additional anodic peaks started to appear at 1.19 V and 1.46 V, which are related to the oxidation of a hydroxyl carbon of β-CD and its further oxidation to carboxylic acid. Subsequently, esterification occurs between the carboxylic and primary hydroxyl groups, forming a dimer, and ultimately resulting in CDP (
The anodic peaks were dramatically increased until the 7th CV cycle and started to become saturated in the following cycle. A non-imprinted copolymer (NICP) as a control was also electrochemically copolymerized using the same process as the MICP without the presence of cortisol. CV curves and field emission scanning electron microscope (FE-SEM) images for each polymer film (PMB, CDP, and MICP) were analyzed to confirm the preparation of MICP on a glassy carbon electrode (GCE) surface (
FE-SEM images obtained for PMB, CDP, and MICP films also confirmed the successful electropolymerization of the proposed MICP film, and the FE-SEM image of the MICP film displayed a more entangled and less porous surface compared to the PMB-only film. Electrochemical extraction of cortisol from the MICP film caused the film more porous, while the electrochemical extraction of cortisol from the control NICP film did not cause a dramatic change in film porosity. This result clearly implies that the morphology change in the MICP film is due to the generation of the receptor cavity within the MICP film, not due to the electrochemical damage of the film. The generation of the receptor cavity in the MICP film was also verified with DPV. The DPV curves obtained from the MICP film showed an increased peak current of PMB oxidation after the extraction of cortisol, which was blocking the current through the PMB, from the MICP film (
The MICP also showed a stable redox reaction throughout 40 repeated CV scans (
Traditional Rct EIS, which uses the charge transfer between the electrode and diffusing redox probe in solution, cannot show the quantum resonant conductance because its measurement needs the DOS exchanging, generated from the charge/discharge of the redox probe anchored to an electrode surface, not from the redox probe in solution.
As described in 1.1 above, quantum EIS using an immobilized PMB redox probe on the GCE surface was performed to investigate quantum electrochemical properties at the interface of the nanoscale MICP film, such as electrochemical capacitance (Cμ), the RC time constant term (τ), and PMB charging resistance (Rq). The impedance Nyquist plot shows a decrease in the imaginary impedance component (Zim), and the capacitance part of the impedance can be measured when the target cortisol binds to the receptor of the MICP film (
The impedance plot was converted to capacitive plots (
Thus, Cμ decreases as the cortisol concentration increases. As shown in
The τ is inversely proportional to the peak frequency (fp) of the imaginary capacitive Bode plot (
The Rs can be obtained from the impedance Nyquist plot at high frequencies as shown in
As shown in
In addition, the “PMB wire” embedded in the MICP film can be represented by an RC circuit and the electron transfer rate (k) could be represented by the following Mathematical Formula 22:
The electron transfer rate across the “PMB wire” in the MICP film decreased when the target cortisol blocked the electron channel of the “PMB wire” when the binding event occurred (
Accordingly, it is certain that the change of G is affected by electron transfer rate as well as capacitance, unlike other quantum properties. These quantum EIS results clearly show that the proposed quantum conductance measurement offers higher sensitivity with a lower LOD for the determination of cortisol compared to the measurements based on other quantum electrochemical responses such as capacitance and electron transfer rate (
The cortisol sensing performance of the proposed quantum EIS method in the MICP sensor of the present invention was compared to those obtained from other electrochemical techniques.
First, Rct EIS, utilizing an external redox probe (Fe(CN)6−3/Fe(CN)6−4) solution, was implemented to measure Rct upon binding of cortisol at the nanoscale MICP interface. The resulting Nyquist plot shows that the nanoscale film has too small resistance to induce a significant change in charge transfer resistance upon cortisol binding (
As shown in
indicates data missing or illegible when filed
indicates data missing or illegible when filed
Affinity-based sensors utilizing classical bioreceptors, such as aptamers and antibodies, are generally suitable for one-time use and also require multiple washing steps with additional regenerating agents (e.g., NaCl, EDTA, NaOH, and SDS, etc.).
On the other hand, the present MICP-based sensor is designed for on-site electrochemical regeneration in the measurement sample solution (due to the electrochemical properties of the used-CD), enabling repetitive measurements without a washing step.
The hydrogen bonds in this complex can be formed between β-CD and the carboxyl group of carbon 3, the hydroxyl group of carbon 11, and the hydroxyl group of carbon 21 in the cortisol molecule (
This oxidation can not only generate a radical cation on the carbon but also induces its polarity. The radical cation transforms to a stable resonance form (oxonium ion) and this structure changes may weaken the hydrogen bond, thus cortisol to be extracted from the complex.
This allows MICP-based cortisol sensors to be regenerated up to nine times without any significant loss of sensing performance with a relative standard deviation of 2.05% (
The binding kinetics was studied by measuring different concentrations of cortisol to estimate the association constant (ka) of the MICP (
indicates data missing or illegible when filed
indicates data missing or illegible when filed
Therefore, although the development of reusable and ultrasensitive affinity-based (bio) sensors is challenging the MICP manufactured in the present invention not only is more advantageous for ultrasensitive detection due to its high association constant, but also can be regenerated by electrochemically-triggered structural changes without multiple washing steps or regenerating reagents. Steroids are chemical compounds with a core structure composed of four “fused” rings and only vary by the functional groups attached to the core rings. This causes their hard to distinguish the specific steroid from others, requiring a high degree of selectivity for steroid (bio) sensors. The relative conductance measured by MICP and NICP in the presence of the same concentration of cortisol and structural analogs (progesterone and prednisolone) showed excellent selectivity for these interferents in MICP (
Cortisol is a steroid hormone secreted in response to stress, and thus plays an important role as a stress biomarker.
Chronic stress is associated with increased risk of mental health, weakening immune responses, and cardiovascular disease. Therefore, effective and reliable cortisol detection is very useful for monitoring the fluctuations of cortisol throughout the day toward comprehensive self-monitoring and personalized healthcare.
Salivary cortisol, which can be easily collected non-invasively, is known to be highly correlated with blood cortisol levels.
Cortisol levels vary according to the circadian rhythm, with concentrations peaking 30 min after waking up and lowest around bedtime.
The present MICP-based cortisol sensor was evaluated in artificial saliva (AS) using quantum EIS. The resulting capacitance Bode plots are shown in
The accuracy for the determination of saliva based on the present MICP-based sensor was validated by LC-MS/MS analysis (FIG. BD). Repetitive measurement (n=4) of saliva samples collected at 2 a.m. and 8 a.m., including electrochemical regeneration steps, shows a relative quantum conductance of 39.69 (±0.039) % and 40.88 (±0.044) %, respectively, demonstrating the proposed cortisol sensor can generate consistent sensing signals and regeneration in human saliva (
In the present invention, quantum electrochemistry was utilized to overcome the existing limitations of affinity-based (bio) sensors for small molecules. Various electrochemical methods have been employed for the manufacture of MICPs, cortisol detection, and sensor regeneration.
Using CV, the nanoscale MICP film with an embedded redox probe can be easily synthesized and easily regenerated without any need of lengthy extraction or several washing steps. The quantum EIS, which measures resonant quantum conductance, enables label-free, ultrasensitive, and selective cortisol monitoring through the decreased conductance response of the “PMB wire” immobilized in the MICP. By integrating mass-producible MICP and the conductance measurement, we have demonstrated an in-situ and continuous cortisol monitoring strategy, promising for wearable health monitoring applications. Using the present MICP-based cortisol sensor, we have successfully measured the salivary cortisol variations following the circadian rhythm and have thoroughly validated using an LC-MS/MS. The nanoscale MICP sensor of the present invention, which is capable of conductance measurements, may be readily expanded to detect various other small molecules. Overall, the new MICP-based cortisol sensing enabling “continuous bind-and-read” provides a reliable and practical approach for in-situ ultrasensitive stress monitoring. The use of quantum electrochemistry with nanoscale MICP for tackling the limitations of affinity-based (bio) sensor paves the way to a new possibility of (bio) sensor applications toward the PoC and wearable device for healthcare.
The sensor according to the present invention can be reused by repeating the oxidation/reduction of a receptor through CV and repeating the separation/binding of the receptor and a small molecule. In other words, when CV is used, nano-sized MIP films with an embedded redox probe can be easily synthesized and easily regenerated without lengthy extraction or multiple washing steps. Quantum EIS for measuring resonant quantum conductance enables label-free, ultrasensitive selective monitoring through the reduced conductance response of a ‘redox probe wire’ immobilized in the MIP. Integrating conductance measurements with mass-producible MIPs enables on-site and continuous monitoring suitable for wearable health monitoring applications.
Number | Date | Country | Kind |
---|---|---|---|
10-2023-0081703 | Jun 2023 | KR | national |